Advertisement

Search Results for "Heron Health Outcomes"

21:59 EDT 23rd May 2013 | BioPortfolio

Original Source: Heron Health

HERON is a privately held healthcare consultancy founded in the UK in 1999 by Paul Howard, John Kerrigan, and Chris Knight. Following over a decade of growth, the Company is still wholly owned and operated by the three co-founders and an entrepreneurial team of over 120, including experts in varied fields of science and business operations. Throughout this period, HERON has grown organically and now operates five offices in four countries. We estimate that HERON is the largest independent provider in the...

Matching Channels

Public Health

Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The main...

Health IT Information Technology

Why Health IT?   Health information technology (Health IT) makes it possible for health care providers to better manage patient care through secure use and sharing of health information - e...

Mental Health

Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing additional physical health problems and costing the economy m...

Sexual Health

The World Health Organization (WHO) definition of sexual health; "the state of physical, emotional, mental and social well-being related to sexuality; it is not merely the absence of disease, d...

Improving health

Matching News

Parexel acquires Heron Group

Parexel, a US-based clinical research organization, has acquired the equity securities of the Heron Group, a life sciences consultancy which provides evidence-based commercialization services to suppo...

Parexel International acquires Heron Group

Parexel International, a global CRO, has acquired all outstanding equity securities of the Heron Group, a Luton, U.K.-based life sciences consultancy that provides evidence-based commercialization ser...

The Role Mood May Play In The Development And Maintenance Of Unhealthy Eating

Taking part in unhealthy eating behaviors may cause women who are concerned about their diet and self-image to experience a worsening of their moods, according to Penn State researchers. In a study, c...

Parexel Acquires Heron Group in Up To $38M Deal

Parexel Upbeat After Strong Quarter, Acquisition of Heron

With a more than 27 percent increase in revenue for Q3 of FY 2013 over the same quarter last year, CRO Parexel has raised its guidance for both the fiscal and calendar year.

WiserTogether, Inc. Announces a Strategic Investment by Blue Heron Capital

WiserTogether, Inc. announced a strategic investment by Blue Heron Capital. Washington, DC based, WiserTogether, Inc. is one of the fastest growing companies in healthcare IT and...

PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy

BOSTON, April 30, 2013 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced that today the Company acquired all of the outstanding...

Research helps unlock gene secrets of autosomal dominant nocturnal frontal lobe epilepsy

In a national research partnership, Dr Sarah Heron from the University of South Australia's Sansom Research Institute, epilepsy research group, has been working to map the genes responsible for a rare...

Matching PubMed Articles

In reply to drs. Rwigema and heron.

Metal Contamination in Select Species of Birds in Nilgiris District, Tamil Nadu, India.

Variation in metal contamination in six species of birds, namely the Cormorant (Phalacrocorax carbo), Cattle Egret (Bubulcus ibis), Little Egret (Egretta garzetta), Pond Heron (Ardeola grayii), Common...

PHYSICAL ACTIVITY AND HEALTH OUTCOMES: EVIDENCE FROM CANADA.

Health production models include participation in physical activity as an input. We investigate the relationship between participation in physical activity and health using a bivariate probit model. P...

SINGLE APPLICATION OF HIGH-INTENSITY FOCUSED ULTRASOUND AS A FIRST-LINE THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER: 5-YEAR OUTCOMES.

Cardiovascular Risk Reduction via Increasing HDL Cholesterol: The Promise of the dal-OUTCOMES Trial.

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement